Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
Abstract
Activator protein 1 (AP-1) is a key transcription factor in the control of several cellular processes responsible for cell survival proliferation and differentiation. Dysfunctional AP-1 expression and activity are involved in several severe diseases, especially inflammatory disorders and cancer. Therefore, targeting AP-1 has recently emerged as an attractive therapeutic strategy for cancer prevention and therapy. This review summarizes our current understanding of AP-1 biology and function as well as explores and discusses several natural bioactive compounds modulating AP-1-associated signaling pathways for cancer prevention and intervention. Current limitations, challenges, and future directions of research are also critically discussed. (C) 2017 Elsevier Ltd. All rights reserved.
Más información
Título según WOS: | ID WOS:000435626500037 Not found in local WOS DB |
Título de la Revista: | PHARMACOLOGICAL RESEARCH |
Volumen: | 128 |
Editorial: | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
Fecha de publicación: | 2018 |
Página de inicio: | 366 |
Página final: | 375 |
DOI: |
10.1016/j.phrs.2017.09.014 |
Notas: | ISI |